VOYA Investment Management
TEVA icon

VOYA Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

VOYA Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.29M Buy
156,077
+11,032
+8% +$367K ﹤0.01% 845
2026
Q1 		$4.37M Sell
145,045
-6,209
-4% -$200K ﹤0.01% 878
2025
Q4 		$4.72M Buy
151,254
+12,019
+9% +$296K ﹤0.01% 891
2025
Q3 		$2.81M Sell
139,235
-37,902
-21% -$666K ﹤0.01% 1094
2025
Q2 		$2.97M Buy
177,137
+1,188
+0.7% +$19.2K ﹤0.01% 1150
2025
Q1 		$2.7M Sell
175,949
-36,574
-17% -$653K ﹤0.01% 1184
2024
Q4 		$4.68M Sell
212,523
-57,221
-21% -$1.04M ﹤0.01% 999
2024
Q3 		$4.86M Buy
269,744
+83,975
+45% +$1.47M 0.01% 1010
2024
Q2 		$3.02M Buy
185,769
+2,947
+2% +$45.4K ﹤0.01% 1183
2024
Q1 		$2.58M Sell
182,822
-245
-0.1% -$3.09K ﹤0.01% 1259
2023
Q4 		$1.91M Buy
183,067
+9,400
+5% +$87.8K ﹤0.01% 1384
2023
Q3 		$1.77M Sell
173,667
-17,531
-9% -$163K ﹤0.01% 1376
2023
Q2 		$1.44M Buy
191,198
+34,346
+22% +$279K ﹤0.01% 1485
2023
Q1 		$1.39M Buy
156,852
+5,037
+3% +$49.8K ﹤0.01% 1505
2022
Q4 		$1.38M Sell
151,815
-10,210
-6% -$89.1K ﹤0.01% 1497
2022
Q3 		$1.31M Sell
162,025
-32,985
-17% -$292K ﹤0.01% 1495
2022
Q2 		$1.47M Sell
195,010
-19,215
-9% -$167K ﹤0.01% 1228
2022
Q1 		$2.01M Buy
214,225
+65,626
+44% +$548K ﹤0.01% 1111
2021
Q4 		$1.19M Sell
148,599
-7,905
-5% -$71.3K ﹤0.01% 1437
2021
Q3 		$1.52M Hold
156,504
– – ﹤0.01% 1314
2021
Q2 		$1.55M Buy
156,504
+644
+0.4% +$6.82K ﹤0.01% 1336
2021
Q1 		$1.8M Sell
155,860
-1,555
-1% -$17.8K ﹤0.01% 1241
2020
Q4 		$1.52M Sell
157,415
-13,464
-8% -$129K ﹤0.01% 1277
2020
Q3 		$1.54M Hold
170,879
– – ﹤0.01% 1116
2020
Q2 		$2.11M Sell
170,879
-1,862
-1% -$21.1K ﹤0.01% 1008
2020
Q1 		$1.55M Buy
172,741
+3,994
+2% +$40.9K ﹤0.01% 1041
2019
Q4 		$1.65M Hold
168,747
– – ﹤0.01% 1189
2019
Q3 		$1.16M Buy
168,747
+49,208
+41% +$377K ﹤0.01% 1265
2019
Q2 		$1.1M Sell
119,539
-3,082
-3% -$37.2K ﹤0.01% 1307
2019
Q1 		$1.92M Buy
122,621
+5,170
+4% +$91.2K ﹤0.01% 1058
2018
Q4 		$1.81M Buy
117,451
+1,866
+2% +$38.3K ﹤0.01% 1029
2018
Q3 		$2.49M Buy
115,585
+1,514
+1% +$35.1K 0.01% 1019
2018
Q2 		$2.77M Buy
114,071
+12,780
+13% +$261K 0.01% 970
2018
Q1 		$1.73M Hold
101,291
– – ﹤0.01% 1106
2017
Q4 		$1.92M Hold
101,291
– – ﹤0.01% 1064
2017
Q3 		$1.78M Hold
101,291
– – ﹤0.01% 1090
2017
Q2 		$3.37M Sell
101,291
-1,252
-1% -$38.8K 0.01% 885
2017
Q1 		$3.29M Buy
102,543
+1,147
+1% +$39.1K 0.01% 899
2016
Q4 		$3.68M Sell
101,396
-1,466,865
-94% -$58.6M 0.01% 859
2016
Q3 		$72.2M Buy
+1,568,261
New +$81.8M 0.14% 136

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

VOYA Investment Management's TEVA Position: Q2 2026 in Review

VOYA Investment Management increased its Teva Pharmaceuticals (TEVA) stake by 7.6% in Q2 2026, buying an estimated $367K and bringing the position to 156,077 shares worth $5.29M. The position accounts for ﹤0.01% of the portfolio, ranked #845.

VOYA Investment Management first reported a position in TEVA in Q3 2016 and has held it in 40 quarters since. The position peaked at $72.2M in Q3 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • VOYA Investment Management held 156,077 shares of Teva Pharmaceuticals worth $5.29M as of Q2 2026.
  • VOYA Investment Management bought 11,032 Teva Pharmaceuticals shares in Q2 2026, an estimated $367K.
  • Teva Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #845 holding.
  • VOYA Investment Management first reported a position in Teva Pharmaceuticals in Q3 2016 and has held it in 40 quarters since.
  • VOYA Investment Management's Teva Pharmaceuticals position peaked at $72.2M in Q3 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.